<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36947300</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Inflammopharmacology</Title><ISOAbbreviation>Inflammopharmacology</ISOAbbreviation></Journal><ArticleTitle>Long COVID prevalence and physiology-centered risks: population-based study in Ukraine.</ArticleTitle><Pagination><StartPage>597</StartPage><EndPage>602</EndPage><MedlinePgn>597-602</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10787-023-01177-1</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Multifaceted long COVID caused by SARS-COV-2 affects all populations in the World and takes priority over any other research topics for health care. The purpose of study is to identify physiology-centered risks, prevalence, symptoms and laboratory findings in patients with long COVID in Ukraine.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective, cohort study was carried out on 332 patients with long COVID after 4&#xa0;weeks and more after acute infection COVID-19 from Jul 1, 2021, to Jul 1, 2022. Physiology-centered risks related to age, gender, body mass index (BMI), marital status and educational capacity, smoking, lifestyle, physical activity, and laboratory findings (before disease), and symptom distribution were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The cohort for the study consisted of 166 females and 107 males (mean age&#x2009;=&#x2009;42; including young 18 (5.4%) and middle- and old-aged adults 314 (96.4%)). Increased BMI was in 61%, and less physical activity-65%. There were 4 clusters of symptoms related to physical, neurocognitive, pulmonary, and pain conditions. 95% of participants had&#x2009;&#x2265;&#x2009;3 symptoms. The most common symptoms were fatigue (90%), muscular pain (85%), anosmia (70%), hair loss (70%), sleep disorders (70%), dyspnea (30%), and brain fog (25%). Among laboratory finding increased CRP (92.6%) and fibrinogen (82.7%) dominated. There are no differences between hospitalized and non-hospitalized patients in distribution symptoms.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The prevalence of long COVID is 23%, and its physiology-centered risk factors are related to age more 38&#xa0;years, female sex, unhealthy lifestyle, increased BMI, and increased inflammatory markers during COVID-19. The most common symptoms are associated with neurocognitive and pain clusters.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Muzyka</LastName><ForeName>Iryna</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-7446-6063</Identifier><AffiliationInfo><Affiliation>Physiology Department, Danylo Halytsky Lviv National Medical University, 69 Pekarska Str, Lviv, 79010, UA, Ukraine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Diseases, CNE "Novoiavorivsk District Hospital Named After Yuri Lypa" Lviv Region, Novoiavorivsk, 81053, UA, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yakhnytska</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9223-5146</Identifier><AffiliationInfo><Affiliation>CNE "Lviv Regional Centre for Emergency Medical Care and Disaster Medicine", Lviv, 79068, UA, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savytska</LastName><ForeName>Maryana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9404-4589</Identifier><AffiliationInfo><Affiliation>Physiology Department, Danylo Halytsky Lviv National Medical University, 69 Pekarska Str, Lviv, 79010, UA, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zayachkivska</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-8792-9204</Identifier><AffiliationInfo><Affiliation>Physiology Department, Danylo Halytsky Lviv National Medical University, 69 Pekarska Str, Lviv, 79010, UA, Ukraine. ozayachkivska@auhs.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, American University of Health Sciences, Signal Hill, CA, 90755, USA. ozayachkivska@auhs.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Inflammopharmacology</MedlineTA><NlmUniqueID>9112626</NlmUniqueID><ISSNLinking>0925-4692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014455" MajorTopicYN="N" Type="Geographic">Ukraine</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cohort study</Keyword><Keyword MajorTopicYN="N">Dysautonomia</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Physiology</Keyword></KeywordList><CoiStatement>The authors have not disclosed any competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>12</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36947300</ArticleId><ArticleId IdType="pmc">PMC10032259</ArticleId><ArticleId IdType="doi">10.1007/s10787-023-01177-1</ArticleId><ArticleId IdType="pii">10.1007/s10787-023-01177-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbasi J, The US. Now has a research plan for long COVID&#x2014;is it enough? JAMA. 2022 doi: 10.1001/jama.2022.14536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.14536</ArticleId><ArticleId IdType="pubmed">35960527</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, Haroon S, Price G, Davies EH, Nirantharakumar K, Sapey E. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk C. Where are we with drug treatments for covid-19? BMJ. 2021 doi: 10.1136/bmj.n1109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1109</ArticleId><ArticleId IdType="pubmed">33962913</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashkirtsev O, Gaevska V, Zimba O, Sagan V. Biological age estimation based on heart rate variability: &#x410; pilot study. Proc Shevchenko Sci Soc Med Sci. 2021;65(2):218&#x2013;239. doi: 10.25040/ntsh2021.02.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.25040/ntsh2021.02.21</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell ML, Catalfamo CJ, Farland LV, Ernst KC, Jacobs ET, Klimentidis YC, et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS ONE. 2021;16(8):e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol. 2016;594(20):5781&#x2013;5790. doi: 10.1113/JP271539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP271539</ArticleId><ArticleId IdType="pmc">PMC5063949</ArticleId><ArticleId IdType="pubmed">27059884</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, Primus-de Jong C, Cleemput I, Van den Heede K. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54(1):1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J Infect Dis. 2022 doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond) 2021;21(1):e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Global map of COVID-19 by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://coronavirus.jhu.edu/map.html</Citation></Reference><Reference><Citation>https://www.nytimes.com/live/2022/03/13/world/ukraine-russia-war#here-are-the-latest-developments-in-ukraine</Citation></Reference><Reference><Citation>Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: a chronic low-grade inflammation and its markers. Cureus. 2022;14(2):e22711. doi: 10.7759/cureus.22711.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.22711</ArticleId><ArticleId IdType="pmc">PMC8967417</ArticleId><ArticleId IdType="pubmed">35386146</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine RL (2022) Addressing the Long-term Effects of COVID-19. JAMA. Published online August 03, 2022. 10.1001/jama.2022.14089https://jamanetwork.com/journals/jama/article-abstract/2795139</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, Yee NTS, Liu C, Nerurkar SN, Kai JCY, Teng MLP, Li X, Zeng H, Borghi JA, Henry L, Cheung R, Nguyen MH. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449&#x2013;1458. doi: 10.1002/jmv.26424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26424</ArticleId><ArticleId IdType="pmc">PMC7436673</ArticleId><ArticleId IdType="pubmed">32790106</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich HG, Brockmann SO, G&#xf6;pel S, Kindle G, Merle U, Steinacker JM, Rothenbacher D, Kern WV, EPILOC Phase 1 Study Group Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ. 2022;379:e071050. doi: 10.1136/bmj-2022-071050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Brockmann SO, G&#xf6;pel S, Kindle G, Merle U, Wolfers K. Association of body mass index with general health, working capacity recovered, and post-acute sequelae of COVID-19. Obesity. 2022 doi: 10.1002/oby.23611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.23611</ArticleId><ArticleId IdType="pmc">PMC9874798</ArticleId><ArticleId IdType="pubmed">36195985</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo S. COVID-19: new disease and chaos with panic, associated with stress. Proc Shevchenko Sci Soc Med Sci [internet] 2020 doi: 10.25040/ntsh2020.01.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.25040/ntsh2020.01.14</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2018) ACTIVE: a technical package for increasing physical activity. World Health Organization, Geneva, 2018. Licence: CC BY-NC-SA 3.0 IGO. ISBN: 9789241514804 9789241514187-eng.pdf (who.int)</Citation></Reference><Reference><Citation>WHO (2021) Obesity. https://www.who.int/news-room/facts-in-pictures/detail/6-facts-on-obesity#:~:text=WHO%20defines%20overweight%20as%20a%20BMI%20equal%20to,as%20a%20result%20of%20being%20overweight%20or%20obese</Citation></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>